Even during the pandemic, the medical community continued their research for novel therapies and new solutions for providing the best possible patient care—the top 5 research updates from the field of dermatology.

#1 Probiotics for psoriasis

In research on translational dermatology, it was shown how probiotics might serve as the new route for treatment of inflammatory skin diseases, including psoriasis. A new probiotic was developed for specific tailoring of inflammatory sin disease, including psoriasis.

#2 Reducing mouth line with silicone pads

Multi-area pads made from medical grade silicone and devised to stimulate cell growth and stimulate collagen and blood flow to assistin reducing fine lines and wrinkles in the mouth area. In sync with the benefits of using silicone to treat scars, the product hydrates wrinkles, refines collagen structure, and flattens outlines through prolonged use.

#3 Role of antihistamines in treating alopecia areata

A new study published in the JAMA assessed the effectiveness of a combination comprising of antihistamines, topical corticosteroids, and superficial cryotherapy to treat alopecia areata.

The study results revealed that after seven months of treatment, 100% of patients taking antihistamines achieved significant hair regrowth compared with 79.3% of patients who were treated only with TCs and SC. Besides, the study’s authors reported no adverse effects from the treatment.

#4 COVID-19 patients experienced skin symptoms

With the growing list of COVID-19 symptoms, the SARS-COV-2 canaffect the lungs and other internal organs, and the senses. Dermatologists have also observed skin reactions in patients with the disease.

These reactions include a “dengue fever-like rash,” a “hives-like rash,” livedo reticularis, a “measles-like rash,” and pernio located on the extremities also referred to as COVID-toes.

#5 New picosecond laser treats pigmentary disorders in darker skin types

A new case report published in the American Society for Laser Medicine and Surgery showed that the new 730-nm picosecond laser possessed strong efficacy and safety in treating endogenous pigmentary disorders on darker skin types.

In this study on two Korean patients with II-IV Fitzpatrick skin types, as well as melasma, freckles, and lentigines, who were treated with 730 nmTi: Sapphire picosecond laser with a pulse duration of 240 picoseconds. The study researchers said that they noticed significant pigmentary reduction within one treatment session, which was well-tolerated without topical anesthesia in both patients. After a 6-week follow-up, no inflammatory hyperpigmentation or re-pigmentation in either patient was seen.

Resource: Petronelli M. Top 20 trending stories of 2020. 2020 December 11. Dermatology Times. Accessed from https://www.dermatologytimes.com/view/top-20-trending-stories-of-2020?utm_source=sfmc&utm_medium=email&utm_campaign=12162020_DER-20-DED0237_Dermavant_Tremfya%20TD_Viewpoints%20TD_DupixentPodcas_DERM_eNL_INTL_ONLY&eKey=cG9vamFpamNwQGdtYWlsLmNvbQ==